跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,498 条关于
“anti-C5”
全部
19,498
临床试验
9,817
药物
3,724
机构
78
资讯
5,879
2年前
FDA Approves Fabhalta (Iptacopan) as First Oral Monotherapy for PNH
2年前
Iptacopan Yields Hematological Improvements in PNH Persistent Anemia
去年
Novartis' Fabhalta Shows Promise in PNH Patients Switching from Anti-C5 Therapies
去年
Breakthrough Treatments Transform Landscape for Rare Hemolytic Anemias: From C5 Inhibitors to Novel Therapeutic Approaches
10个月前
InflaRx to Report Phase 2a Results for Oral C5aR Inhibitor INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
去年
FDA Initiates Review of Roche's Monthly Injectable Crovalimab for Rare Blood Disorder PNH
3年前
Iptacopan Shows Promise in Complement-Inhibitor-Naïve PNH Patients
2年前
Novartis Highlights New Data on Kisqali, Iptacopan, and Scemblix at SABCS and ASH
去年
Federal Circuit Ruling Opens New Patent Challenge Avenue for Life Sciences Companies
去年
InflaRx's Vilobelimab Receives Positive CHMP Opinion for COVID-19-Induced ARDS
第 1 页,共 588 页
上一页
下一页